Praxis Precision Medicines (PRAX) Total Current Liabilities (2019 - 2026)

Praxis Precision Medicines' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $50.2 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 27.12% year-over-year to $50.2 million; the TTM figure through Mar 2026 stood at $50.2 million (up 27.12% YoY), while the FY2025 annual figure was $59.8 million, up 59.18% from the prior year.
• Total Current Liabilities was $50.2 million for Q1 2026 at Praxis Precision Medicines, down from $59.8 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $59.8 million in Q4 2025 to a low of $15.7 million in Q4 2023.
• Historically, Total Current Liabilities has averaged $35.0 million across 5 years, with a median of $34.3 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities jumped 229.18% in 2022, then slumped 54.14% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $34.3 million in 2022, then plunged by 54.14% to $15.7 million in 2023, then surged by 138.43% to $37.6 million in 2024, then surged by 59.18% to $59.8 million in 2025, then slipped by 15.94% to $50.2 million in 2026.
• The last three Total Current Liabilities figures came in at $50.2 million (Q1 2026), $59.8 million (Q4 2025), and $52.9 million (Q3 2025), per Business Quant data.